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 ABSTRACT 
Nonsense-mediated mRNA decay (NMD) is a pathway that detects and degrades 
mRNAs containing premature translation termination codons (PTCs). In humans, 
recognition of these aberrant mRNAs requires an exon-junction-complex (EJC) placed 
downstream of a PTC and the dynamic interaction of several UPF/SMG proteins, the 
ribosome and the EJC. These interactions promote UPF1 phosphorylation by SMG1 
kinase, triggering mRNA degradation. Recent progress in our understanding of NMD 
has been achieved by combining cryo-electron microscopy, high-resolution structures, 
interaction data and functional assays. These studies uncovered a mechanism regulating 
SMG1 kinase as well as the architecture and functional implications of a complex 
containing UPF1, UPF2, UPF3 and EJC. Collectively these findings reveal the role of 
protein scaffolds and conformational changes in NMD regulation. 
 
 
 
Large macromolecular complexes and transient interactions regulate NMD 
Nonsense-mediated mRNA decay (NMD) is an evolutionary conserved eukaryotic post-
transcriptional surveillance pathway that discriminates normal versus aberrant 
translation termination events in mRNAs containing premature translation termination 
codons (PTCs) [1]. PTCs result from germ-line mutations in a large number of inherited 
genetic disorders as well as errors during transcription and splicing. NMD detects PTC-
containing mRNAs during the pioneer round of translation, and these are targeted for 
degradation to prevent the synthesis of truncated proteins. NMD also regulates the 
steady-state level of a wide range of physiological substrates [2]. 
Work over the years has provided significant insights into the molecular mechanisms of 
aberrant mRNA detection in the NMD pathway [1,3-7]. NMD requires translating 
ribosomes and a signal downstream of the stop codon to define the context of 
translation termination as physiological or aberrant. The mechanistic details and 
specificities in each organism are a matter of debate and intense research [8-16]. In 
humans, the exon-junction-complex (EJC), four proteins assembled onto mRNA at a 
few nucleotides upstream of the exon–exon boundary upon splicing, is a major 
downstream element promoting NMD (Figure 1a). NMD is elicited when termination 
of translation occurs prematurely at least 50–55 nucleotides upstream of a 3’ exon–exon 
junction [1,3]. Despite intensive research, we do not fully understanding the molecular 
basis of this 50-55 nucleotide rule. According to current models, a large complex 
bridging the ribosome and an EJC, and containing the three UP-Frameshift proteins, 
UPF1, UPF2 and UPF3, assembles only when a downstream EJC comes into proximity 
of a ribosome that has terminated prematurely (Figure 1a) [1,3-7,17]. UPF1 is an RNA 
helicase that associates with ribosomes by interacting with eukaryotic release factors 
(eRFs) eRF1 and eRF3. UPF1 can interact also with UPF2. UPF2 can bind UPF3, 
which is anchored to the EJC. UPF3 is found as two homologous proteins UPF3a and 
UPF3b in human cells. Upon formation of this large complex, SMG1 (Suppressor with 
Morphogenetic effect on Genitalia 1), a  430 kDa serine-threonin kinase belonging to 
the phosphatidylinositol 3-kinase-related protein kinase (PIKK) family [18], 
phosphorylates UPF1 [19]. Phospho-UPF1 determines the fate of the mRNA towards 
degradation [20]. 
 A molecular view of NMD regulation provided by EM 
Despite recent advances in the field, our understanding of the molecular basis of NMD 
is incomplete by the lack of a detailed structural view of the multiple interactions 
regulating this pathway. Most of our structural knowledge has been obtained by X-ray 
crystallography of UPF proteins and partial complexes (Figure 1) [21, 22, 23, 24, 
27]. Elena Conti and colleagues (Max Planck Institute, Martinsried) recently solved 
several crystal structures of UPF1 in a closed conformation [22] (Figure 1b), which 
were compared with the structure UPF1 bound to the C-terminal domain of UPF2 
solved by Cusack and colleagues (Max Planck Institute, Grenoble) [23] (Figure 1c). 
These structures revealed that a large conformational change relocates the cysteine-
histidine-rich (CH) domain of UPF1, and the helicase activity is activated. UPF2 
interacts with an N-terminal region of UPF3 and the structure of a complex containing 
the interacting domains of each protein has also been solved [27] (Figure 1d).  A C-
terminal peptide of UPF3 is sufficient to provide the link between UPF3 and the EJC as 
revealed by the structure of a UPF3 fragment bound to the EJC [24] (Figure 1e). 
A full mechanistic understanding of the NMD pathway will require defining the 
structures of large and transient macromolecular complexes by integrating different 
methodologies. X-ray crystallography provided the essential high-resolution 
information of those most stable arrangements and sub-complexes. 3D-electron 
microcopy (3D-EM), particularly EM performed on frozen hydrated samples at liquid 
nitrogen temperatures (cryo-electron microscopy, cryoEM), is a powerful method to 
solve larger complexes containing several NMD factors as well as their complexes with 
nucleic acids, especially when these complexes are labile and/or showing flexible 
conformations. Interpretation of the cryoEM densities could be typically performed by 
fitting atomic structures using positional restrains provided by complementary 
biochemical and biophysical methods [28]. 
 
EM combined with functional assays reveals SMG1 kinase regulation by SMG8 
SMG1 triggers NMD by phosphorylating the UPF1 helicase, but little is known about 
the mechanisms by which this kinase activity is confined to the context of an aberrant 
mRNA [29]. In 2009, Shigeo Ohno, Akio Yamashita and colleagues at Yokohama 
University described two proteins, SMG8 and SMG9, that co-purified with SMG1 and 
which were essential for NMD [30]. In collaboration with Ohno and Yamashita, we 
have described the overall architecture of SMG1 and the modulation of its kinase 
activity by the interaction with SMG8 and SMG9 [31,32]. SMG1 comprises several 
conserved domains at the C-terminus, including the catalytic PI3K kinase domain, and a 
long stretch of multiple helical repeats, mostly HEAT (huntingtin, elongation factor 3, 
A subunit of PP2A and TOR1) repeats, organized as super-helical structures at the N-
terminus [19]. SMG1 and the SMG1-SMG9 complex appeared in EM as “question 
mark” shaped-molecules with a large “head” region and a protruding “arm” (Figure 
2a). SMG1 C-terminal end was located at the “head” region, which showed similarities 
with the C-terminus of DNA-PKcs (DNA-dependent Protein Kinase catalytic subunit), 
a member of the PIKK family that has been extensively characterized [33]. SMG1 N-
terminal end was arranged as an “arm” extending from the catalytic C-terminus. A 
combination of EM, mapping experiments and functional assays revealed that this 
helical N-terminal domain interacted with SMG9, which in turn recruited SMG8 [32]. 
SMG8 was identified by comparing images of SMG1-SMG8-SMG9 and SMG1-SMG9 
(Figure 2b) [32]. Therefore, SMG1 helical region functions as a scaffold for the 
assembly of a larger complex, a property described for other PIKKs [33] as well as 
other proteins containing HEAT repeats [34,35]. Interestingly, SMG8 binding down-
regulated SMG1 despite interacting far from the kinase domain. Large-scale 
conformational changes were observed in the N- and C-terminal regions of SMG1-
SMG9 after SMG8 recruitment, which we propose down-regulate the kinase (Figure 
2c). This model is consistent with the complex regulation of PI3-kinases [18] and the 
large conformational changes described for HEAT repeats proteins interacting with 
other proteins [34,35]. 
These results provide some insights into SMG1 regulation but new questions arise. 
What steps remove SMG8 inhibition to facilitate UPF1 phosphorylation? SMG1 
activation could be achieved by disrupting the SMG1-SMG8-SMG9 complex and/or 
additional conformational changes induced by other factors or proteins binding to 
SMG1. The answer maybe found by elucidating how this inhibitory mechanism is 
coordinated with the rest of events that take place during recognition of an aberrant 
mRNA. UPF2 binds a C-terminal fragment of SMG1, adding a potential new level of 
regulation [36].  
 
Architecture of the UPF-EJC complex resolved by cryoEM 
A recent study has provided a pseudo-atomic model of a complex containing UPF1, 
UPF2, UPF3 and EJC (UPF-EJC hereafter) by combining a cryoEM structure of the 
complex with partial crystal structures, and integrating positional restrains obtained by 
labeling experiments of the components [37] (Figure 3a). UPF-EJC was reconstituted 
from the individual components by Elena Conti and colleagues (Max Planck Institute, 
Martinsried) and analyzed by our group using EM. Interestingly, UPF-EJC was only 
stable at high concentrations, whereas it disassembled at the concentrations required for 
EM analysis. Therefore, the complex was stabilized with a mild fixation coupled to 
purification in a sucrose gradient using the GraFix method [38]. We determined the 3D 
structure of this 390 kDa complex at ~16 Å resolution using cryoEM. The positions of 
the individual components were mapped by antibody labeling, the structural 
characterization of several sub-complexes (UPF1-UPF2-UPF3-EJC, UPF2-UPF3-EJC, 
UPF1-UPF2-UPF3, UPF2-UPF3 and UPF2) by EM and the fitting of available crystal 
structures and homology models. The pseudo-atomic model suggested that the 
requirement for a minimum of 50-55 nucleotides between a stop codon and a 
downstream splice junction might be interpreted in molecular terms as physical and 
geometrical constraints. A minimal distance of several tens of nucleotides between the 
ribosome and the exon-exon junction could be required to accommodate UPF-EJC, 
considering the distance of an RNA-bound EJC to the exon-exon junction, the RNA 
covered by the EJC itself and the distance between the EJC and the RNA-binding 
region of UPF1 in the context of the UPF-EJC [37]. 
UPF1 is part of SURF (SMG1-UPF1-Release-Factors), a probably transient NMD 
complex assembled at the ribosome that contains SMG1, UPF1 and release factors 
eRF1 and eRF3 [36]. UPF1 would be expected to locate at the 5’end of the EJC bound 
RNA as part of SURF (Figure 1a). We assessed whether UPF1 was placed towards the 
5’ or the 3’ end of the EJC by reconstituting UPF-EJC with an EJC bound to RNAs 
labeled with streptavidin at each end. Mechanistically, this allowed addressing that 
UPF1 was positioned towards the substrate of its helicase activity (the RNA 3’ end) in 
the context of UPF-EJC rather than towards the ribosome (Figure 3b). Remarkably, 
recent findings have revealed that UPF1 ATPase activity in the 5’ to 3’ direction is 
essential to strip proteins and dismantle the downstream mRNP during NMD [39]. This 
suggested that cryoEM had trapped a transient NMD complex at a stage when UPF1 is 
ready to function as a helicase towards the 3’ end of the mRNP. How is UPF1 that is 
initially in complex with SMG1 and the ribosome as part of SURF relocated to the 
RNA 3’ end at a later stage of the NMD reaction? This transition might be part of the 
dynamics connecting early and late events during recognition of aberrant mRNAs with 
short-lived transient complexes regulating SMG1 activation and UPF1 phosphorylation. 
 
EM and mass spectrometry show that UPF2 is an open ring-like scaffold 
coordinating the assembly of the surveillance complex 
The UPF-EJC structure revealed that the crosstalk between UPF1, UPF2 UPF3 and the 
EJC involves a set of interactions with UPF2 as a core scaffold as well as multiple 
conformational changes [37]. UPF2 appears as a distorted open-ring and its two ends, 
corresponding to the N- or C-terminal regions of UPF2, grab and reposition the CH 
domain of UPF1, inducing an open unwinding-competent conformation. UPF1 helicase 
regions stick out in UPF-EJC, being accessible to RNA binding (Figure 3b). Other 
regions of the UPF2 ring interact with UPF3. Interestingly, EM images of UPF2 alone 
showed open rings with certain flexibility, suggesting conformational changes in the 
ring as it closes around UPF1. These were confirmed by a mass spectrometry (MS) 
analysis performed by Henning Urlaub and colleagues (Max Planck Institute, 
Göttingen) [37,40]. UPF1-UPF2-UPF3-EJC, UPF2-UPF3-EJC and UPF1-UPF2-
UPF3 complexes, after stabilization by glutaraldehyde cross-linking, were treated with 
trypsin. Detected peptides were those that had not been modified by the crosslinker 
either because they were the core of the proteins or because they corresponded to 
inaccessible regions resulting from protein-protein interactions within UPF-EJC. The 
comparison of peptides obtained for UPF-EJC with those from complexes lacking either 
UPF1 or EJC confirmed the EM model by revealing that the N- and C-terminal regions 
of UPF2 interact with UPF1. Interestingly, these experiments also revealed 
conformational changes in UPF2 when the ring closes around UPF1. Some regions in 
UPF2 were accessible to solvent or protected from crosslinking by the EJC when either 
bound or not to UPF1 respectively. 
 
Conclusions and outlook 
The crosstalk between the stalled ribosome and the EJC involves a number of 
SMG/UPF proteins that interact, either sequentially or concomitantly, ensuing mRNA 
degradation. NMD factors interact forming several complexes containing different 
subunits and conformations. Many of these interactions will be labile and short-lived. 
Recent EM studies integrating structures resolved by X-ray crystallography and 
information provided by labeling experiments, functional assays and mass spectrometry 
have provided important insights into the complexity of NMD [32, 37]. UPF1 binds 
to the ribosome as part of a complex with released factors and SMG1 (SURF) when the 
ribsosome encounters a stop codon (Figure 1a). SMG1 kinase activity is down 
regulated by SMG8 and SMG9 (Figure 2). Only when translation termination is 
premature, interactions linking SURF components to a downstream EJC can be 
established. As part of this large complex, UPF2 forms an open ring that interacts with 
UPF1 and induces an active conformation of this RNA helicase, whereas UPF3 brings 
UPF2 to the EJC (Figure 3). At some stage, SMG1 phosphorylates UPF1, which 
transits from the SURF complex to the 3’ side of the EJC, poised to strip proteins at the 
3’ end of the mRNP (Figure 3). Many questions remain open. The quest for a complete 
understanding of the molecular basis of the 50-55 nucleotide rule is still open. At what 
stage does UPF1 phosphorylation take place? Does UPF1 bind mRNA as part of 
SURF? How is SMG8 inhibition of SMG1 removed? Can UPF1 exist simultaneously 
bound to components of SURF and UPF2 as part of the large surveillance complex 
hypothesized? Some evidence suggests that UPF1 probably cannot bind eRFs and UPF2 
simultaneously and thus it may transit from one complex to another. Is UPF1 5’ to 3’ 
helicase activity maintained active in complex with UPF2 or could UPF1 
phosphorylation maintain an activated conformation without UPF2?  
The answer to these questions will probably benefit from the structural 
characterization of several NMD complexes, a challenge requiring a combined effort of 
cryoEM and X-ray crystallography. But a clear mechanistic understanding of NMD will 
demand in addition defining the correct sequence of interactions, incorporating the time 
dimension to relate the static structural views provided by cryoEM and X-ray 
crystallography in the context of the dynamics of NMD. 
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FIGURE LEGENDS 
Figure 1. (a) Current models for the NMD pathway propose that the EJC is a major 
determinant for detection of PTCs and discrimination of aberrant mRNAs in humans 
[1,3-7]. SMG1, UPF1 and release factors eRF1 and eRF3 interact to form the SURF 
complex in association with the ribosome [36]. A molecular link between SURF 
components and a downstream EJC is required to trigger UPF1 phosphorylation by the 
SMG1 kinase (indicated as an arrow). UPF2 and UPF3 required to bridge UPF1 and the 
EJC [17]. SMG1 kinase is regulated by SMG8 and SMG9 [30], but interactions of 
SMG1 and UPF2 have also been described [36]. Structural insights into the mechanism 
for detecting PTCs in the NMD pathway have been obtained mostly by X-ray 
crystallography studies. The crystal structures of the UPF1 helicase (yellow color) in 
closed [22] (b) and open conformations [23] (c) reveal a displacement of the CH 
domain (indicated with an arrow) upon UPF2 binding (blue color). The CH domain 
regulates the activation of UPF1 by keeping UPF1 inactive in the closed conformation. 
The two RecA domains of UPF1 helicase region have been labeled. A complex 
comprising interacting fragments of UPF2 (blue color) and UPF3b (yellow color) [27] 
(d), as well as a complex between a small UPF3b peptide (green color) sufficient to 
recognize the EJC complex (orange and red colors) [24] (e) have also been solved. 
Figure 2. (a) 2D averages of EM images obtained for SMG1 (not shown) and SMG1-
SMG9 [32] reveal two distinct regions, which were interpreted by comparison with 
the crystal structure of DNA-PKcs [33] and a simulated density map of DNA-PKcs 
crystal structure at a resolution comparable to EM. The “head” region comprises the C-
terminal domains of SMG1 including the catalytic PI3K domain. The N-terminal helical 
regions appear as a protruding “arm” in EM images. (b) Positioning SMG8 and SMG9 
in SMG1-SMG8-SMG9 was achieved by comparison of EM images for each of the 
complexes [32]. SMG-8 was identified as a spot of density bound to the helical repeat 
region. (c) Model of SMG1 kinase regulation based on EM, interaction data and 
functional assays [31-32]. N-terminal helical repeats in SMG1 bind SMG9, and 
SMG9 recruits SMG8 to the complex. SMG8 and SMG9 could bind SMG1 sequentially 
or as a preformed complex. SMG8 binding induces large-scale conformational changes 
that correlate with a down-regulation of SMG-1 kinase. 
 
 
Figure 3. (a) The pseudo-atomic model of the UPF1-UPF2-UPF3-EJC complex is 
shown in two different views [37]. The model is based on the cryoEM structure of the 
UPF-EJC complex, represented as a transparent density, and the fitting of the atomic 
structures of EJC-bound to a small fragment of UPF3b and containing a short RNA 
fragment (shown in black) (PDB 2XB2) [24], of UPF1 bound to the C-terminal domain 
of UPF2 (PDB 2WJV) [23], of the C-terminal MIF4G3 domain of UPF2 bound to an N-
terminal fragment of UPF3 (PDB 1UW4) [27] and homology models for MIF4G1 and 
MIF4G2 domains in UPF2 [37]. Positioning of the atomic structures into the cryoEM 
map was based on protein and RNA labeling experiments as well as mass spectrometry 
data [37]. (b) Cartoon model for the architecture of the UPF-EJC surveillance 
complex [37]. UPF2 is a distorted open ring that binds UPF1 and UPF3. UPF3 
recruits UPF1-UPF2 to the EJC. UPF2 stabilizes an open “active” conformation of 
UPF1 by displacing the CH domain (black arrow). The complex places the UPF1 
helicase poised to remodel the 3’ end of the mRNPs, rationalizing recent findings 
showing that UPF1 ATPase activity is required to remodel the 3’ end of the mRNP [39]. 
Color codes: UPF1 (yellow), UPF2 (blue), UPF3 (green), EJC (orange and red), RNA 
in EJC (black). 
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